Ikarian Capital’s Aptose Biosciences, Inc. APTO Stock Holding History

Ikarian Capital’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-238	Closed	-$147K	–	220
2022 Q1	$147K	Buy	238 +11	+5%	+$6.08K	0.02%	173
2021 Q4	$138K	Hold	227	–	–	0.02%	167
2021 Q3	$224K	Sell	227 -4	-2%	-$5K	0.02%	203
2021 Q2	$346K	Hold	231	–	–	0.03%	197
2021 Q1	$622K	Buy	231 +222	+2,467%	+$440K	0.02%	251
2020 Q4	$18K	Hold	9	–	–	﹤0.01%	224
2020 Q3	$23K	Buy	+9	New	+$22.4K	﹤0.01%	171
2020 Q1	–	Sell	-2,244	Closed	-$5.72M	–	187
2019 Q4	$5.72M	Buy	+2,244	New	+$2.92M	0.93%	35

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAWC

P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ikarian Capital's APTO Position: Q2 2022 in Review

Ikarian Capital sold out of Aptose Biosciences, Inc. (APTO) in Q2 2022, closing a stake of 238 shares — an estimated $147K sold.

Ikarian Capital first reported a position in APTO in Q4 2019 and held it in 8 quarters. The position peaked at $5.72M in Q4 2019. 48 funds tracked by Wall St. Rank hold APTO as of Q2 2022.

Ikarian Capital reported no remaining Aptose Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
Ikarian Capital sold 238 Aptose Biosciences, Inc. shares in Q2 2022, an estimated $147K.
Ikarian Capital first reported a position in Aptose Biosciences, Inc. in Q4 2019 and held it in 8 quarters.
Ikarian Capital's Aptose Biosciences, Inc. position peaked at $5.72M in Q4 2019.
48 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2022.

Based on Ikarian Capital's 13F filing for Q2 2022, filed 12 Aug 2022.